No Detail Found!

Association of neuregulin-1 with hormonal and lipid profile in women with polycystic ovarian syndrome

Author(s)
Omar Tareq Zaidan Chemistry & Biochemistry Department, College of Medicine, Al-Nahrain University,Baghdad,Iraq
Raed Jassim Al-Tamimi Chemistry & Biochemistry Department, College of Medicine, Al-Nahrain University, Baghdad, Iraq
Fadia J. Alizzi Al Mustansiriyah College of Medicine, Department of Obstetrics, Gynecology and Infertility, Al-Yarmouk Teaching Hospital,Baghdad,Iraq
Qasim Sharhan Al-Mayah Medical Research Unit, College of Medicine, Al-Nahrain University,Baghdad,Iraq
Abstract
Background & objective: Polycystic ovarian syndrome (PCOS) is a disorder of the reproductive aged women, which may affect fertility of these women from 14-45 y of age. Neuregulin-1 (NRG-1) is a trophic factor that contains an epidermal growth factor (EGF)-like domain, and has been shown to be associated with the regulation of inflammation and ovulation. We evaluated the role of NRG-1 and its relationship with hormonal and lipid profile in women with PCOS. Methodology: This was a case-control study which included 60 women, known to be suffering from PCOS and another 60 age-matched women, who had regular menstrual cycle, as a control group. Blood samples were collected from Infertility Clinic/ Al-Yarmouk Teaching Hospital. Hormonal and lipid profiles were measured using standard methods. Enzyme linked immunosorbent assay (ELISA) was used to measure serum level of NRG-1. Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of NRG-1. Results: The median serum level of neuregulin in patients was 2.73 pg/mL (range = 1.13-7.39 pg/mL) which was higher than that of controls (median = 2.1 pg/mL, range = 0.33-7.39 pg/mL) with a significant difference the area under the curve (AUC) was 0.652, 95%CI = 0.545-0.758, P = 0.008. The sensitivity and specificity of the test at cut off value of NRG-1 = 2.25 were 62% and 52%, respectively. Neuregulin-1 displayed a significant negative correlation with anti-Müllerian hormone (AMH) (r = -0.324, P = 0.038). Conclusions: Serum level of neuregulin-1 is increased in women with polycystic ovarian syndrome, but has a poor diagnostic value, and its negative correlation with anti-Müllerian hormone. However, the diagnostic value of neuregulin-1 is poor and cannot be used in early diagnosis of polycystic ovarian syndrome. 
Publication Details
Page(s) 509-516
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 28, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
Infertility, Infertility, Polycystic Ovarian Syndrome, Infertility, Neuregulin-1
References
Mohd M,Maqbool M,Dar MA,Mushtaq I . .Polycystic Ovary Syndrome, a modern epidemic: An overview. J Drug Delivery Ther, 20219(3) : 641-4.
Cespedes JC,Liu M,Harbuzariu A,Nti A,Onyekaba J,Cespedes HW,Bharti PK .2018 .. Neuregulin in Health and Disease. Int J Brain Disord Treat, 4(1) : 1410024.
Limanaqi F,Biagioni F,Ryskalin L,Busceti CL,Fornai F. Molecular Mechanisms Linking ALS .2019 .. 2019 Oct, 4 : 450.
Nakano N,Kanekiyo K,Nakagawa T,Asahi M,Ide C. .2016 .NTAK/neuregulin-2 secreted by astrocytes promotes survival and neurite outgrowth of neurons via ErbB3. Neurosci Lett, 04 : 88-94.
Legro RS .2003 .Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev. , 24(3) : 0004-12.
Kahsar-Miller MD,Nixon C,Boots LR,Go RC,Azziz R .2001 .Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril, 0282(00) : 01662-9.
Legro RS,Driscoll D,Strauss JF,Fox J,Dunaif A .1998 .Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A, 95(25) : 14956-60.
Azziz R,Kashar-Miller MD .2000 .Family history as a risk factor for the polycystic ovary syndrome. J Pediatr Endocrinol Metab, 13(Suppl 5) : 1303-6.
Malini NA .2017 .Roy George K. Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS) - Clinical based case control study. Gen Comp Endocrinol, 12 : 51-57.
Rasool SUA,Ashraf S,Nabi M,Rashid F,Fazili KM,Amin S. .2019 .Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome. Diabetes Metab Syndr, 05(3) : 2098-2105.
Khudhair M. .2013 .Evaluation of some hematological and biochemical parameters for women with polycystic ovary syndrome in Wasit Governorate. Wasit J Pure Sci, 10(4) : 185-193.
Islam H,Masud J,Islam YN,Haque FKM . .An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options. Womens Health (Lond)., : .
Maarouf IA,Mubarak ZM .2018 .Study of follistatin and sex hormones level in women with polycystic ovarian syndrome in Baghdad. Tikrit J Pure Sci, 10(4) : 514-6.
Alhassan SM,Elmugadam A,Abubaker NE,Elfadil GA NE .2022 .Testosterone level correlates significantly with luteinizing hormone to follicle-stimulating hormone ratio among women with polycystic ovary syndrome: A cross sectional study. F1000Research, 10 : 152.
Cander S,Şişman P,ÖzGül Ö .2022 .Evaluation of insulin resistance and vitamin D levels in patients with polycystic ovary syndrome. Turkish J Inter Med, 10 : 66-72.
Rosenfield RL,Ehrmann DA .2016 .The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev, 37(5) : 1104-520.
Al-Deresawi MS,Alfaisal AH .2015 .Two novel missense mutations in exon 9 of TPO gene in Polycystic Ovary Syndrome patients with hypothyroidism. J Biotechnol Res Center, 9(10) : 401-37.
Ibrahim TK,Al-Assie AH,Mossa H. .2020 .A physiological and molecular study of leukemia patients in Kirkuk city. J Trop Med Publ Health, 3(10) : 137-148.
Koppali S,Reddy B,Paluru R .2017 .Role of Steroid Hormones in Polycystic Ovarian Syndrome (PCOS) in South Indian Women. Int J Res Ayurveda Pharm, 10 : 082118-4343.
Khmil M,Khmil S,Marushchak M. .2020 .Hormone imbalance in women with infertility caused by polycystic ovary syndrome: is there a connection with body mass index. Open Access Maced J Med Sci, : 731-737.
Rosenfield RL .2015 .The Diagnosis of Polycystic Ovary Syndrome in Adolescents. Pediatrics, 136(6) : 1430-65.
Zhao H,Lv Y,Li L,Chen ZJ .2016 .. Genetic Studies on Polycystic Ovary Syndrome. Best Pract Res Clin Obstet Gynaecol, 04 : 56-65.
Seow KM,Chang YW,Chen KH,Juan CC,Huang CY,Lin LT . .Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome. Int J Mol Sci. 2020 Oct, 21(21) : 8147.
Kloos J,Coyne K,Weinerman R. .2022 .The relationship between antiMüllerian hormone, body mass index and weight loss: A review of the literature. Clin Obes, 12(6) : e12559.
Tawfeq M,Sarhat E .2023 .Metformin effects on neuregulin-1 in polycystic ovarian women. Georgian Med News, : 56-62.
Arpacı H. Circulating .2018 .-1 levels in polycystic ovary syndrome. J Obstet Gynaecol, 39(4) : 504-509.
Banerjee S,Mishra S,Xu W,Thompson WE,Chowdhury I .2022 .Neuregulin-1 signaling regulates cytokines and chemokines expression and secretion in granulosa cell. J Ovarian Res, 15(1) : 86.
Noma N,Kawashima I,Fan HY,Fujita Y,Kawai T,Tomoda Y .2011 .LH-induced neuregulin 1 (NRG-1) type III transcripts control granulosa cell differentiation and oocyte maturation. Mol Endocrinol, 25(1) : 0225-16.
Jeong H,Kim J,Lee Y,Seo JH,Hong SR,Kim A .2014 .Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines. Oncol Rep, 32(3) : 1218-24.
0

Citations

0

Downloads

56

Views